Nepafenac Versus Ketorolac Eye Drops in Prevention of Intraoperative Miosis During Cataract Surgery
Status:
Unknown status
Trial end date:
2020-03-30
Target enrollment:
Participant gender:
Summary
This study aim at determining the efficacy of Nepafenac and Ketorolac in obtaining adequate
intraoperative mydriasis and preventing miosis during cataract surgery. It also compare the
efficacy of both Nepafenac versus Ketorolac, and determine the more effective agent in
preventing miosis during cataract surgery. The investigators try to determine if the effect
of preoperative NSAIDs agents use would show a financial benefit, or this manoeuvre would add
a financial load on the patients who are candidate for cataract surgery.